PT3038596T - Composições e métodos para a remoção de tatuagens - Google Patents

Composições e métodos para a remoção de tatuagens

Info

Publication number
PT3038596T
PT3038596T PT148389356T PT14838935T PT3038596T PT 3038596 T PT3038596 T PT 3038596T PT 148389356 T PT148389356 T PT 148389356T PT 14838935 T PT14838935 T PT 14838935T PT 3038596 T PT3038596 T PT 3038596T
Authority
PT
Portugal
Prior art keywords
tattoos
compositions
removal
methods
Prior art date
Application number
PT148389356T
Other languages
English (en)
Original Assignee
Univ Dalhousie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dalhousie filed Critical Univ Dalhousie
Publication of PT3038596T publication Critical patent/PT3038596T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A61Q1/145—Tattoo removal

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT148389356T 2013-08-30 2014-08-28 Composições e métodos para a remoção de tatuagens PT3038596T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361871929P 2013-08-30 2013-08-30

Publications (1)

Publication Number Publication Date
PT3038596T true PT3038596T (pt) 2020-04-03

Family

ID=52585331

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148389356T PT3038596T (pt) 2013-08-30 2014-08-28 Composições e métodos para a remoção de tatuagens

Country Status (9)

Country Link
US (5) US9801799B2 (pt)
EP (1) EP3038596B1 (pt)
AU (1) AU2014311225B2 (pt)
BR (1) BR112016004372B1 (pt)
CA (1) CA2921762C (pt)
DK (1) DK3038596T3 (pt)
ES (1) ES2782360T3 (pt)
PT (1) PT3038596T (pt)
WO (1) WO2015027328A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017044815A1 (en) * 2015-09-11 2017-03-16 Rxi Pharmaceuticals Corporation Methods for treating skin disorders and conditions utilizing haptens
HK1251188A1 (zh) * 2015-10-30 2019-01-25 达布尼专利有限责任公司 淡化和去除纹身的系统、设备和方法
EP3284505B1 (de) 2016-08-18 2019-03-27 nolax AG Verfahren zum entfernen von tätowierungen und verwendung eines microneedle-patches in einem verfahren zum entfernen von tätowierungen
RU2722455C1 (ru) * 2020-01-28 2020-06-01 Марина Леонидовна Тынянова Способ удаления татуировок у человека и композиция для его осуществления

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540934A (en) 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
GB9620504D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
US20100146256A1 (en) 2000-01-06 2010-06-10 Super Talent Electronics Inc. Mixed-Mode ROM/RAM Booting Using an Integrated Flash Controller with NAND-Flash, RAM, and SD Interfaces
GB0118517D0 (en) 2001-07-30 2001-09-19 Mitsubishi Tokyo Pharm Inc Compound
EP1603476A4 (en) 2003-03-13 2010-01-13 3M Innovative Properties Co PROCESS FOR REMOVING TATTOO
US20050201959A1 (en) * 2004-03-11 2005-09-15 Vvii Newco 2003, Inc. Methods and compositions for altering skin coloration
WO2005107751A1 (en) * 2004-05-06 2005-11-17 Merck & Co., Inc. Methods for treating arthritic conditions in dogs
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
US20070081962A1 (en) 2005-10-06 2007-04-12 Amit Munshi Novel delivery of immune response modifiers for removal of chronic tattoos
US20070218116A1 (en) * 2006-03-14 2007-09-20 Schwendener Reto A Compositions and methods for the treatment of tumors and tumor metastases
US9278233B2 (en) 2008-12-04 2016-03-08 Biochemics, Inc. Methods and compositions for tattoo removal
EP2440250A1 (en) 2009-06-11 2012-04-18 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Targeted liposomes comprising n-containing bisphosphonates and uses thereof
US8637569B2 (en) * 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
EP2363111A1 (en) * 2010-03-01 2011-09-07 Combino Pharm, S.L. Stable pharmaceutical composition comprising bisphosphonate
WO2011132826A1 (en) * 2010-04-19 2011-10-27 Snu R&Db Foundation Transdermal drug delivery system and pharmaceutical composition for preventing or treating bone diseases
WO2011159951A2 (en) * 2010-06-17 2011-12-22 Sanford-Burnham Medical Research Institute Targeting tumor associated macrophages using bisphosphonate-loaded particles
US20120310140A1 (en) * 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
CN103327965B (zh) * 2011-01-25 2017-07-18 宝洁公司 脂质体和包含脂质体的个人护理组合物
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture

Also Published As

Publication number Publication date
US9801799B2 (en) 2017-10-31
AU2014311225B2 (en) 2019-12-19
US20190008744A1 (en) 2019-01-10
EP3038596A1 (en) 2016-07-06
DK3038596T3 (da) 2020-04-06
CA2921762C (en) 2022-07-12
CA2921762A1 (en) 2015-03-05
EP3038596A4 (en) 2017-02-08
US11344490B2 (en) 2022-05-31
US10105302B2 (en) 2018-10-23
US20250161183A1 (en) 2025-05-22
US20170042781A1 (en) 2017-02-16
EP3038596B1 (en) 2020-01-08
US12226508B2 (en) 2025-02-18
NZ717166A (en) 2021-05-28
AU2014311225A1 (en) 2016-03-10
BR112016004372B1 (pt) 2021-01-05
ES2782360T3 (es) 2020-09-14
US20160279045A1 (en) 2016-09-29
WO2015027328A1 (en) 2015-03-05
US20220257489A1 (en) 2022-08-18

Similar Documents

Publication Publication Date Title
IL273205A (en) Preparations and methods
IL273090B (en) Methods and preparations for the treatment of cancer
GB2521022B (en) Compositions and methods
SMT201900635T1 (it) Composizioni e metodi di attivazione della segnalazione dipendente dallo "stimolatore di geni interferone"
IL265876A (en) Preparations that include 15-ohepa and methods of using them
SG11201601412XA (en) Compositions and methods for the treatment of presbyopia
GB201308072D0 (en) Compositions and methods
SG11201509136YA (en) Cenicriviroc compositions and methods of making and using the same
PT3021839T (pt) Composições para o tratamento da fibrose
ZA201509262B (en) Tuberculosis compositions and methods of using the same
GB201305813D0 (en) Compositions and methods
SG10201710538XA (en) Compositions and methods for treating skin
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
EP2964610A4 (en) VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF
PT3038596T (pt) Composições e métodos para a remoção de tatuagens
EP3068431A4 (en) Methods and compositions for the treatment of hcmv
GB201300628D0 (en) Compositions comprising 15-OHEPA and methods of using the same
GB201322617D0 (en) Methods and compositions
GB201312393D0 (en) Compositions and Methods
GB201310349D0 (en) Composition and method of use thereof
GB201301928D0 (en) Composition and method of use thereof